ipilimumab,nivolumab,Oxaliplatin,Capecitabine,gimeracil,oteracil,tegafur,Pembrolizumab,Atezolizumab,5-Fluorouracil,Calciumfolinat,docetaxel,durvalumab
bms,Ono Pharmaceutical,nordic group,otsuka,Merck,Roche,Astrazeneca
['key,note,426', 'keynote,91', 'key,note,57', 'gi ', 'key,note,001', 'ts,perio,1', 'leucovo', 'nivo', 'gastroesophageal', 'cisplatin', 'ts,perio,01', 'docetaxel', 'dante', 'durva', 'kn57', 'ts,perio,i', 'gastric', 'pembro', 'atezo', 'capecitabine', 'attraction-5', 'esophageal', 'oxaliplatin', 'astrazeneca', 'msd']
 pr. s-e al-batran explores immunotherapy's role in adj and neoadju treatment for upper gi cancer. while there's been no significant improvement in os yet, future trials should aim at better patient selection, emphasizing pd-l1 status. 
MD, Medical Oncology Resident at @HUG